Guanylyl Cyclase-B Dependent Bone Formation in Mice is Associated with Youth, Increased Osteoblasts, and Decreased Osteoclasts

Brandon M Wagner, Jerid W Robinson, Timothy C.R. Prickett, Eric A. Espiner, Sundeep Khosla, Dana Gaddy, Larry J. Suva, Lincoln R. Potter

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


C-type natriuretic peptide (CNP) activation of guanylyl cyclase-B (GC-B) catalyzes the synthesis of cGMP in chondrocytes and osteoblasts. Elevated cGMP stimulates long bone growth, and inactivating mutations in CNP or GC-B reduce cGMP, which causes dwarfism. GC-B7E/7E mice that express a GC-B mutant that cannot be inactivated by dephosphorylation exhibit increased CNP-dependent GC-B activity, which increases bone length, as well as bone mass and strength. Importantly, how GC-B increases bone mass is not known. Here, we injected 12-week-old, wild type mice once daily for 28 days with or without BMN-111 (Vosoritide), a proteolytically resistant CNP analog. We found that BMN-111 treated mice had elevated levels of osteocalcin and collagen 1 C-terminal telopeptide (CTX) as well as increased osteoblasts and osteoclasts. In BMN-111 injected mice, tibial mRNAs for Rank ligand and osteoprotegrin were increased and decreased, respectively, whereas sclerostin mRNA was elevated 400-fold, consistent with increased osteoclast activity and decreased osteoblast activity. Mineral apposition rates and trabecular bone mass were not elevated in response to BMN-111. Because 9-week-old male GC-B7E/7E mice have increased bone mass but do not exhibit increased mineral apposition rates, we examined 4-week-old male GC-B7E/7E mice and found that these animals had increased serum osteocalcin, but not CTX. Importantly, tibias from these mice had 37% more osteoblasts, 26% fewer osteoclasts as well as 36% and 40% higher mineral apposition and bone formation rates, respectively. We conclude that GC-B-dependent bone formation is coupled to an early juvenile process that requires both increased osteoblasts and decreased osteoclasts.

Original languageEnglish (US)
Pages (from-to)506-518
Number of pages13
JournalCalcified Tissue International
Issue number5
StatePublished - Nov 2022

Bibliographical note

Funding Information:
This work was supported by a University of Minnesota Foundation Bridge Grant to LRP, a University of Minnesota-Mayo Clinic Partnership grant to LRP and SK, a University of Minnesota Academic Health Center Faculty Research and Development Grant to LRP, National Institutes of Health T32DK007203 Grant to JWR, and Grants from the Fund for Science and the Hormone Receptor Fund to LRP. National Institutes of Health Grant R01HD102909 to LJS. We thank James Herrick and Theresa Hefferan from the Biomaterials and Histomorphometry Core Laboratory at the Mayo Clinic for performing the histomorphometry studies. Finally, we are grateful to Drs. Laurinda Jaffe, Leia Shuhaibar, and Siu-Pok Yee for generating and allowing us to use the GC-B mice for our studies . 7E/7E

Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.


  • Achondroplasia
  • Guanylyl cyclase
  • Natriuretic peptide
  • Osteoblast
  • Osteoclast
  • cGMP

PubMed: MeSH publication types

  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural


Dive into the research topics of 'Guanylyl Cyclase-B Dependent Bone Formation in Mice is Associated with Youth, Increased Osteoblasts, and Decreased Osteoclasts'. Together they form a unique fingerprint.

Cite this